These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 34536743)
1. Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer. Ding S; Sun X; Zhu L; Li Y; Chen W; Shen K Int Immunopharmacol; 2021 Nov; 100():108122. PubMed ID: 34536743 [TBL] [Abstract][Full Text] [Related]
2. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature. Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954 [TBL] [Abstract][Full Text] [Related]
3. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients. Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y Front Immunol; 2021; 12():805883. PubMed ID: 35095892 [TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma. Liu J; Lu J; Li W Front Immunol; 2021; 12():738068. PubMed ID: 34630418 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer. Qiu C; Wang W; Xu S; Li Y; Zhu J; Zhang Y; Lei C; Li W; Li H; Li X BMC Cancer; 2024 Apr; 24(1):402. PubMed ID: 38561760 [TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer. Zhang X; Shi X; Zhao H; Jia X; Yang Y Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055 [TBL] [Abstract][Full Text] [Related]
10. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer. Wang Z; Liu H; Gong Y; Cheng Y Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948 [TBL] [Abstract][Full Text] [Related]
11. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer. Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W Gene; 2020 Dec; 762():144974. PubMed ID: 32707305 [TBL] [Abstract][Full Text] [Related]
12. PANoptosis-related molecular clustering and prognostic signature associated with the immune landscape and therapy response in breast cancer. Cao Y; Guan L; Yang L; Wei C Medicine (Baltimore); 2024 Sep; 103(37):e39511. PubMed ID: 39287311 [TBL] [Abstract][Full Text] [Related]
13. A novel immune-related prognostic index for predicting breast cancer overall survival. Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847 [TBL] [Abstract][Full Text] [Related]
14. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
15. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
16. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer. Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184 [TBL] [Abstract][Full Text] [Related]
17. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma. Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253 [TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer. Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777 [TBL] [Abstract][Full Text] [Related]
19. An immune-related prognostic signature for predicting breast cancer recurrence. Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G Cancer Med; 2020 Oct; 9(20):7672-7685. PubMed ID: 32841536 [TBL] [Abstract][Full Text] [Related]
20. Identification of Breast Cancer Subtypes Based on Endoplasmic Reticulum Stress-Related Genes and Analysis of Prognosis and Immune Microenvironment in Breast Cancer Patients. Yi C; Yang J; Zhang T; Qin L; Chen D Technol Cancer Res Treat; 2024; 23():15330338241241484. PubMed ID: 38725284 [No Abstract] [Full Text] [Related] [Next] [New Search]